Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-8111017
  • Global Cardiovascular Ultrasound Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: October 2017 | Report Code: HME-8111017

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

An ultrasound system creates images known as Sonograms. Sonogram emit high frequency sound waves, which passes through the body and create images that can be seen on a screen..The global cardiovascular ultrasound system market is expected to rise at a CAGR of 6% during the forecast period 2016-2023. Owing to technological advancement, increasing prevalence of cardiovascular diseases and advantage of echocardiography over invasive cardiac diagnostic procedures.

The key factor driving the growth of global cardiovascular ultrasound system market is the increasing healthcare expenditure. The increase in healthcare expenditure across the globe has led to raised adoption of cardiovascular ultrasound system. Thus, increasing healthcare spending by people would give increase to adoption of ultrasound treatment. Owing to increasing disposable income around the world households are eager to spend more for medically advanced and proficient treatments.  According to institute of health metrics and evaluation, global spending on health is expected to reach to $ 18.28 trillion worldwide by 2040. Furthermore, spent on health is expected to increase to 9% of GDP globally by 2040.According to organization for economic cooperation and development (OECD), in United States the healthcare expenditure has observed a high growth of 3.8% from 2012 to 2015. Besides in Asia Pacific healthcare expenditure is increasing. According to the India brand Equity foundation (IBEF) in 2013, India healthcare expenditure was $96.3 billion which is expected to increase by 12% around $195.7 billion by 2018.Moreover, in India health care sector is increasing faster owing to rising investment by public and private player as well as adoption of new medical technologies. For instance, according to ministry of health department of India, in 2016, development of 50 medical technologies was aimed. Healthcare market is expected to rise at a CAGR of 16.5% during the forecast period.Moreover, as per organisation of economic coporation and development, in 2012 healthcare expenditure in per capital at Japan was $4017 which is increased to $4150 in 2015. However, insufficient reimbursement scenario and economic influence of adopting new technologies restraining the growth of cardiovascular ultrasound system market.

Source: OBRC Analysis.

The report on global cardiovascular ultrasound system market includes test type, technology, device display and end user.

Based on test type, report further segmented as:

  • Transthoracic Echocardiogram
  • Transesophageal Echocardiogram
  • Stress Echocardiogram
  • Other Echocardiograms





On the basis of technology, report is further segmented as:

  • 2D Ultrasound
  • 3D & 4D ultrasound
  • Doppler Imaging




Global cardiovascular ultrasound system market segmented on the basis of device display:

  • Colordisplay
  • Black & White display



End user of cardiovascular ultrasound system market include:

  • Hospital and cardiology centers
  • Home and ambulatory care settings
  • Others end users




Global cardiovascular ultrasound system market report covers segmentation analysis of test type, technology, device display and end user. Report further covers segments of test type which includes transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram and other echocardiograms. The stress echocardiogramis the leading test type segment in 2016. This is owing to the major advantages such as ready availability, incremental value, low capital cost. Moreover, stress echocardiogram provide data of cardiac muscle and valves before as well as after the stress of the heart and muscle. Report further covers segments of technology which includes 2D Ultrasound, 3D & 4D ultrasound and doppler imaging. The device display of cardiovascular ultrasound system market includes Color display and Black & White Display. Whereas the end users of cardiovascular ultrasound system market include hospital and cardiology centres, home and ambulatory care settings and others end users. The home and ambulatory care settings segment is expected to grow at fastest rate during the forecast period owing to growing the usage of echocardiographs at the patient’s house.

The global cardiovascular ultrasound system market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





Geographically, Europe is the largest market region for global cardiovascular ultrasound system market in terms of market revenue share in 2015. The key factors driving the market growth in Europe region is increasing cardiovascular disease. According to European heart network in Europe, each year cardiovascular disease causes around 3.9 million deaths in Europe. Moreover, in 2015 there were around 11.3 million new cases of cardiovascular disease and 6.1 million new cases of cardiovascular disease in European Union. Furthermore, every year more than around 85 million people suffer from cardiovascular disease. The main cause of death in Europe was CVD and approximately 45% people died out of all deaths in 2015.However, Asia Pacific is expected to emerge as the fastest growing market region during the forecast period 2016-2023 owing to increasing healthcare expenditure and medical tourism.

The major market players of the global cardiovascular ultrasound system market are:

  • PHILIPS HEALTHCARE (THE NETHERLANDS)
  • SIEMENS HEALTHCARE (GERMANY)
  • HITACHI MEDICAL CORPORATION (JAPAN)
  • TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN)
  • MINDRAY MEDICAL INTERNATIONAL LIMITED (CHINA)
  • OTHERS







These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, product and service launch are the key strategy adopted by the companies in the cardiovascular ultrasound system market.

For Example;

In 2015, Philips Healthcare had announced to launch a Lumify app based on ultrasound solution that is designed for emergency department as well as urgent care center and clinical setting.

In Nov 2016, Toshiba Medical System Corporation has launched the premium Aplio™ i-series ultrasound platform. The Aplio™ i-series powerful performance helps to raise diagnostic accuracy and offers cost effective and safer solution than other radiation emitting modalities.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in cardiovascular ultrasound system market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as test type, technology, device display and end user of cardiovascular ultrasound system market.
  • Identify and understand the strength, opportunities, challenges and threat of the cardiovascular ultrasound market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of voice communication segment market.
  • Detailed analysis of various the regulatory policies which are affecting the global cardiovascular ultrasound market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global cardiovascular ultrasound market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the cardiovascular ultrasound system market, with giving extensive SCOT analysis of key companies. 

Key findings of the global cardiovascular ultrasound market:

  • The global cardiovascular ultrasound system market is expected to rise at a CAGR of 6% during the forecast period 2016-2023.
  • The key factor driving the growth of global cardiovascular ultrasound system market is the increasing prevalence of cardiovascular diseases.
  • The home and ambulatory care settings segment is expected to grow at fastest rate during the forecast period 2016-2023.
  • Asia Pacific is expected to emerge as the fastest growing market region during the forecast period 2016-2023.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS&TOP COMPANY ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. TECHNOLOGICAL ADVANCEMENT
3.1.2. INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES
3.1.3. ADVANTAGE OF ECHOCARDIOGRAPHY OVER INVASIVE CARDIAC DIAGNOSTIC PROCEDURES
3.1.4. INCREASING HEALTHCARE EXPENDITURE
3.2. MARKET RESTRAINTS
3.2.1. INSUFFICIENT REIMBURSEMENT SCENARIO
3.2.2. ECONOMIC INFLUENCE OF ADOPTING NEW TECHNOLOGIES
3.3. MARKET OPPORTUNITIES
3.3.1. UNTAPPED APAC REGION HAS HUGE SCOPE FOR ULTRASOUND SYSTEM
3.3.2. MINIATURIZATION OF ULTRASOUND DEVICES
3.4.   MARKET CHALLENGES 
3.4.1. STRINGENT GOVERNMENT POLICIES AND REGULATIONS
3.4.2. LACK OF SKILLED SONOGRAPHERS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TEST TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL STRESS ECHOCARDIOGRAM MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL OTHER ECHOCARDIOGRAMS MARKET 
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.2. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TECHNOLOGY
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL 2D MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL 3D & 4D MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL DOPPLER IMAGING MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY DEVICE DISPLAY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL COLOR DISPLAYMARKET 
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL BLACK & WHITE DISPLAY MARKET 
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY END USER
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL HOSPITALS/CARDIOLOGY CENTERSMARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL AMBULATORY/HOME CARE MARKET
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL OTHERS MARKET
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER & ACQUISITION
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS
 
6. GEOGRAPHY ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. GE HEALTHCARE (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. PHILIPS HEALTHCARE (THE NETHERLANDS)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. SIEMENS HEALTHCARE (GERMANY)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. HITACHI MEDICAL CORPORATION (JAPAN)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN).
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.5.5. STRATEGIC ANALYSIS
7.6. MINDRAY MEDICAL INTERNATIONAL LIMITED ( CHINA)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. SAMSUNG ELECTRONICS CO., LTD. ( SOUTH KOREA)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.7.5. STRATEGIC ANALYSIS
7.8. FUJIFILM HOLDINGS CORPORATION ( JAPAN)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. ESAOTE S.P.A. ( ITALY)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.9.5. STRATEGIC ANALYSIS
7.10. CHISON MEDICAL IMAGING CO., LTD. (CHINA.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. ULTRASOUND TECHNOLOGIES LTD.( UK)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. UNETIXS VASCULAR, INC. ( U.S)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. KALAMED MEDICAL SYSTEMS ( GERMANY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. TRIVITRON HEALTHCARE ( INDIA)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. SUPERSONIC IMAGINE (FRANCE)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKETBY TEST TYPE 2014-2023 ($ MILLION)
2. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL STRESS ECHOCARDIOGRAM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL OTHER ECHOCARDIOGRAMS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BYTECHNOLOGY2014-2023 ($ MILLION)
7. GLOBAL 2D MARKETBY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL 3D & 4D MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL DOPPLER IMAGINGMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY DEVICE DISPLAY 2014-2023 ($ MILLION)
11. GLOBAL COLORDISPLAY MARKETBY GEOGRAPHY2014-2023 ($ MILLION)
12. GLOBAL BLACK & WHITE  DISPLAY MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
13. GLOBAL CARDIOVASCULAR ULTRASOUND SYSTEM MARKET BY END USER 2014-2023 ($ MILLION)
14. GLOBAL HOSPITAL AND CARDIOLOGY CENTERS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
15. GLOBAL HOME AND AMBULATORY CARE SETTINGS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
16. GLOBALOTHER END USERS MARKET BY GEOGRAPHY2014-2023 ($ MILLION)
17. NORTH AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
18. EUROPE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
19. ASIA PACIFIC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
20. REST OF THE WORLD CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL TRANSTHORACIC ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
2. GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
3. GLOBAL STRESS ECHOCARDIOGRAM MARKET 2014-2023 ($ MILLION)
4. GLOBAL OTHER ECHOCARDIOGRAMS MARKET 2014-2023 ($ MILLION)
5. GLOBAL 2D MARKET2014-2023 ($ MILLION)
6. GLOBAL 3D & 4D MARKET 2014-2023 ($ MILLION)
7. GLOBAL DOPPLER IMAGINGMARKET 2014-2023 ($ MILLION)
8. GLOBAL COLORDISPLAY MARKET 2014-2023 ($ MILLION)
9. GLOBAL BLACK & WHITE  DISPLAY MARKET 2014-2023 ($ MILLION)
10. GLOBAL HOSPITAL AND CARDIOLOGY CENTERS MARKET 2014-2023 ($ MILLION)
11. GLOBAL HOME AND AMBULATORY CARE SETTINGS MARKET 2014-2023 ($ MILLION)
12. GLOBALOTHER END USERS MARKET2014-2023 ($ MILLION)
13. UNITED STATES (U.S.) CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
14. CANADA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
15. UNITED KINGDOM (UK) CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
16. FRANCE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
17. GERMANY CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
18. RUSSIA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
19. ROE CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
20. INDIA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
21. CHINA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
22. JAPAN CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
23. AUSTRALIACARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
24. ROAPAC CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
25. LATIN AMERICA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
26. MENA CARDIOVASCULAR ULTRASOUND SYSTEM MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

Go To Top
viewthroughconversion